- Home
- MKL vs PODD Comparison
MKL vs PODD Comparison
Compare MKL & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MKL
- PODD
- Stock Information
- Founded
- MKL 1930
- PODD 2000
- Country
- MKL United States
- PODD United States
- Employees
- MKL N/A
- PODD N/A
- Industry
- MKL Property-Casualty Insurers
- PODD Medical/Dental Instruments
- Sector
- MKL Finance
- PODD Health Care
- Exchange
- MKL Nasdaq
- PODD Nasdaq
- Market Cap
- MKL 24.4B
- PODD 21.5B
- IPO Year
- MKL 1986
- PODD 2007
- Fundamental
- Price
- MKL $1,993.45
- PODD $330.77
- Analyst Decision
- MKL Hold
- PODD Strong Buy
- Analyst Count
- MKL 3
- PODD 18
- Target Price
- MKL $1,820.33
- PODD $332.22
- AVG Volume (30 Days)
- MKL 47.0K
- PODD 703.4K
- Earning Date
- MKL 07-30-2025
- PODD 08-07-2025
- Dividend Yield
- MKL N/A
- PODD N/A
- EPS Growth
- MKL 8.84
- PODD N/A
- EPS
- MKL 167.05
- PODD 3.32
- Revenue
- MKL $16,454,135,999.00
- PODD $2,359,500,000.00
- Revenue This Year
- MKL N/A
- PODD $24.54
- Revenue Next Year
- MKL $5.22
- PODD $17.48
- P/E Ratio
- MKL $11.92
- PODD $99.54
- Revenue Growth
- MKL 1.66
- PODD 26.00
- 52 Week Low
- MKL $1,494.00
- PODD $180.31
- 52 Week High
- MKL $2,075.92
- PODD $334.18
- Technical
- Relative Strength Index (RSI)
- MKL 56.27
- PODD 68.80
- Support Level
- MKL $1,918.50
- PODD $302.41
- Resistance Level
- MKL $1,980.00
- PODD $334.18
- Average True Range (ATR)
- MKL 30.90
- PODD 8.76
- MACD
- MKL 5.57
- PODD 3.53
- Stochastic Oscillator
- MKL 85.90
- PODD 94.09
About MKL Markel Group Inc.
Markel's primary business is property and casualty insurance. The company focuses primarily on specialty lines, ranging from areas such as executive liability to commercial equine insurance. The acquisition of Alterra in 2013 added substantial reinsurance operations, which now account for a little over 10% of premiums. The company uses capital generated by its insurance operations to buy noninsurance operations in diverse areas, such as bakery equipment manufacturing and residential homebuilding.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetics are using it worldwide.